www.fdanews.com/articles/92492-neurochem-licenses-alza-pain-drug
Neurochem Licenses Alza Pain Drug
April 25, 2007
Canadian drug firm Neuromed said Tuesday it has licensed the exclusive U.S.
rights to the potential opioid pain drug Oros Hydromorphone from Alza.
UPI